Search Results

Displaying Results 5201-5225 of 26807 "'D'"

Jul 23, 2026, 09:00 ET Velocity Advisory Group unveils comprehensive research analyzing 11 years and 23,000+ behavioral assessments to reveal how the workforce now communicates

has occurred.The report translates DISC — the framework that maps how people prefer to communicate — into four intuitive archetypes: the Eagle (D - direct), the Parrot (I – influencing), the Dove (S - steady), and the Owl (C - analytical). Tracking these styles across more than a decade, the analysis

More news about: Velocity Advisory Group


Jul 23, 2026, 09:00 ET UST Retains Top Employer Honors from TEI, Earning Global Recognition for the Eighth Consecutive Year

and led by our purpose, we partner with our clients from design to operation. Our AI-driven digital solutions, proprietary platforms, engineering, R&D, products, and innovation ecosystem turn core challenges into impactful, disruptive business outcomes. With deep industry knowledge and a future-ready

More news about: UST


Jul 23, 2026, 09:00 ET HOPPR Brings AI Foundation Models to Chest CT, Expanding Developer Access Across Its Growing Medical Imaging Portfolio

introduced its HOPPR® EF Chest CT Narrative Model, a foundation model that processes 3D chest CT volumes and generates narrative language describing image characteristics across pulmonary, mediastinal, cardiac, upper

More news about: HOPPR


Jul 23, 2026, 08:47 ET Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid Tumors

assess the safety and tolerability of BAT8013. Key objectives of the study are to determine the maximum tolerated dose and recommended Phase 2 dose (RP2D), and to evaluate pharmacokinetics and preliminary efficacy in patients with advanced solid tumor.  In addition, Bio-Thera Solutions is developing several

More news about: Bio-Thera Solutions, Ltd


Jul 23, 2026, 08:30 ET TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

T-cell engaging antibody that binds to the CD3 receptor expressed on the surface of T-cells and G protein-coupled receptor class C group 5 member D (GPRC5D), a novel multiple myeloma target which is highly expressed on the surface of multiple myeloma cells and nonmalignant plasma cells, as well as some

More news about: Johnson & Johnson


Jul 23, 2026, 08:30 ET The Sky Is No Longer the Limit: Drones as a Service Adoption Reaches Critical Mass Projected to Exceed $250 Billion Growth

infrastructure, manufacturing, energy and agricultural activity. The Company plans to target drone-based services including construction progress monitoring and 3D site mapping through its ZenaWorx platform, land surveying and geomatics, utility and powerline inspections, industrial facility, transportation infrastructure,

More news about: Market News Updates


Jul 23, 2026, 08:17 ET JumpStart VC Fest Returns to Cleveland September 29-30, Spotlighting Midwest Startup Momentum

jumpstartinc.org.About Burton D. Morgan FoundationBurton D. Morgan Foundation is a private foundation based in Northeast Ohio dedicated to advancing the principles of free enterprise and entrepreneurship.

More news about: JumpStart Inc.


Jul 23, 2026, 08:05 ET Accord BioPharma Announces Commercial Availability of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)

therapy; severe hypocalcemia and fatal cases have been reported with denosumab products. Adequately supplement all patients with calcium and vitamin D.In patients without advanced CKD who are predisposed to hypocalcemia and disturbances of mineral metabolism, assess serum calcium and mineral levels

More news about: Accord BioPharma


Jul 23, 2026, 08:00 ET SimBioSys and Ferrum Health Partner to Expand Access to AI-Powered Surgical Planning Through Ferrum's AI Governance Suite

and reliability."TumorSight Viz is an FDA-cleared AI-powered platform that transforms standard breast MRI into interactive, patient-specific 3D visualizations—providing surgeons with deeper anatomical insight to support more informed and individualized surgical planning. Through integration with

More news about: SimBioSys


Jul 23, 2026, 08:00 ET Kavalan Named 'Whisky of the Year' For Second Year Running at IWC 2026

Year:Kavalan Peatist Oloroso Sherry Cask Single Cask Strength Single Malt WhiskyMaster Distiller of the Year:Zerose Yang - Head of R&DAvailability: Kavalan Peatist Oloroso Sherry Cask is available now in Taiwan and selected international markets, including France, Canada,

More news about: Kavalan Whisky


Jul 23, 2026, 08:00 ET Stretch Zone Announces Grand Opening in Mount Prospect, IL

difference. We knew this was a service we believed in and something our community could truly benefit from." Li currently serves as a Senior R&D Manager at Kraft Heinz and holds a Ph.D. in Food Science and Human Nutrition. His wife works as a data scientist. Together, they have previously invested

More news about: Stretch Zone


Jul 23, 2026, 08:00 ET Kavalan é eleito o "Whisky do Ano" pelo segundo ano consecutivo na IWC 2026

Ano:Kavalan Peatist Oloroso Sherry Cask Single Cask Strength Single Malt WhiskyMestre Destilador(a) do Ano:Zerose Yang, chefe de P&DDisponibilidade: o Kavalan Peatist Oloroso Sherry Cask já está disponível em Taiwan e em alguns mercados internacionais, como França,

More news about: Kavalan Whisky


Jul 23, 2026, 08:00 ET Kavalan es designado "whisky del año" por segundo año consecutivo en el IWC 2026

Oloroso, edición de barril único intenso de malta pura)Maestro destilador del año:Zerose Yang: director de Investigación y Desarrollo (I+D)Disponibilidad: Peatist Oloroso Sherry Cask de Kavalan ya está disponible en Taiwán y en determinados mercados internacionales, entre ellos

More news about: Kavalan Whisky


Jul 23, 2026, 08:00 ET Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States

electronics, mobility, energy, food, medical products, and biotechnology.NAGASE is not only a trading company, but also possesses manufacturing and R&D functions. By combining these functions with high-added-value information obtained through its global trading networks with customers around the world,

More news about: Precision Diabetes, Inc.


Jul 23, 2026, 08:00 ET Sunshine Silver Mining & Refining Reports Drill Results Exceeding 1,000 grams per tonne Silver from Multiple Zones including New "10 Vein"

are estimated using current geological interpretations related to the core axis angle as logged by the core logging geologist and compared with the 3D geological model to determine the interception angle. These true widths may be revised as additional drilling and modelling are completed.Qualified

More news about: Sunshine Silver Mining & Refining


Jul 23, 2026, 07:31 ET Le pôle pétrochimique de la Méditerranée orientale, développé par Rönesans, attire plus de 3 milliards de dollars américains d'investissements

objectif est de faire d' le pôle industriel le plus compétitif de Turquie en regroupant les sites de production et les infrastructures logistiques à proximité des infrastructures énergétiques et portuaires, afin d'offrir aux investisseurs tout ce dont ils ont besoin au sein d'un même site d' . 

More news about: Rönesans Holding


Jul 23, 2026, 07:29 ET Ribo publie des résultats positifs suite à l'essai de Phase 2a réalisé sur le vortosiran - Premières données cliniques au monde sur l'inhibition du facteur XI par pARNi après administration de plusieurs doses chez des patients atteints de coronaropathie

(Ribo, 6938.HK) est une entreprise innovante de R&D au stade clinique qui se consacre au développement de médicaments à base d'acide nucléique et de produits connexes basés sur la technologie de l'interférence par ARN (ARNi). Grâce à ses capacités de R&D innovantes et à ses plateformes technologiques

More news about: Suzhou Ribo Life Science Co., Ltd.


Jul 23, 2026, 07:00 ET Knowledge Grid Launches to Pioneer the Cognitive Data Layer -- the AI-Native Data Foundation for Cybersecurity

Backed by 7 issued US patents and 15+ years of R&D, the KG Cognitive Data Platform transforms raw security telemetry into AI-ready data at ingest — so downstream AI can finally detect the threats legacy tools structurally can't seeSALT LAKE CITY,

More news about: Knowledge Grid


Jul 23, 2026, 07:00 ET Three Corners of Deception 2 Movie Teaser 1

judges are taking advantage of the powerless.The film specifically targets the actions of individuals identified as Judge W. B. and Judge M. D., Judge L. M., as well as an attorney J. C., who is accused of copyright infringement for financial gain. While identifying officials by initials makes

More news about: Dr. Meleeka Clary


Jul 23, 2026, 07:00 ET RAYZON Solar and Caelux Partner to Scale Next-Generation Solar Tech for "Make in India" Initiative

manufacturing ecosystem. Its portfolio includes high-efficiency L'LIOS N-Type TOPCon bifacial modules, backed by continuous innovation through its R&D collaboration with the University of New South Wales (UNSW). Demonstrating its commitment to sustainability,RAYZON Solar is a participant of

More news about: Caelux Corporation


Jul 23, 2026, 07:00 ET Harley-Davidson Delivers Second Quarter Financial Results and Raises Full-Year Guidance

be imposed by the U.S. on foreign goods or rebalancing or other tariffs recently imposed or that may be imposed by foreign countries on U.S. goods; (d) accurately analyze, predict and react to changing market conditions, interest rates, and geopolitical environments, and successfully adjust to shifting

More news about: Harley-Davidson, Inc.


Jul 23, 2026, 06:57 ET Trooly Raises Nearly $20M Seed and Launches AI Research Platform for 45-Minute In-Depth Interviews With Global Consumers

45-minute conversation can hold when the interviewer keeps asking the right next question. The new funding goes toward exactly that bet: continued R&D on the core product and its multimodal voice-agent technology, building out a global panel of interview participants, and expanding among globally

More news about: Trooly


Jul 23, 2026, 06:30 ET LAZARD REPORTS SECOND QUARTER AND FIRST HALF 2026 RESULTS

Adjusted diluted weighted average shares (d)110,458,354

More news about: Lazard


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.